alovudine has been researched along with Cell Transformation, Neoplastic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboagye, EO; Doblas, S; Döring, C; Faber, C; Fricke, IB; Griffiths, JR; Heinzmann, K; Heller, A; Hermann, S; Honess, DJ; Jacobs, AH; Just, N; Rieder, N; Schäfers, KP; Schelhaas, S; Schneider, R; Sinkus, R; Smith, DM; Wachsmuth, L | 1 |
| Akoury, J; Douglas, KA; Gadgeel, S; Lawhorn-Crews, JM; Li, J; Mangner, TJ; McHugh, CI; Polin, L; Ratnam, M; Shields, AF; Thipparthi, MR | 1 |
| Aboagye, EO; Faber, C; Griffiths, J; Heinzmann, K; Hermann, S; Honess, DJ; Jacobs, AH; Kopka, K; Kuhlmann, MT; Müller-Tidow, C; Schäfers, M; Schelhaas, S; Schneider, R; Schober, O; Smith, DM; Viel, T; Wachsmuth, L; Wagner, S | 1 |
| Boellaard, R; Chamuleau, ME; Cillessen, SA; Hoekstra, OS; Hoetjes, N; Jauw, Y; Regelink, JC; Rizvi, SN; van de Ven, PM; Wondergem, MJ; Zijlstra, JM; Zweegman, S | 1 |
| Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G | 1 |
| Erler, J; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Perryman, L; Poulsen, HS; Stockhausen, MT | 1 |
| Cass, CE; Gati, WP; Graham, K; Jans, HS; McEwan, A; McQuarrie, S; Mercer, J; Paproski, RJ; Wuest, M; Young, JD | 1 |
| Kjaer, A; Madsen, J; Persson, M; Ploug, M; Rasmussen, P | 1 |
| Asher, C; Chu, SK; Garwin, GG; Johnson, BW; Krohn, KA; Li, T; Miyaoka, RS; Plotnik, DA; Schwartz, JL | 1 |
1 trial(s) available for alovudine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
Topics: Adult; Aged; Area Under Curve; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Follicular; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Remission Induction; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
8 other study(ies) available for alovudine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Thymidine Metabolism as a Confounding Factor for 3'-Deoxy-3'-
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artifacts; Biological Transport; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Female; Fluorouracil; HCT116 Cells; Humans; Leucovorin; Mice; Organoplatinum Compounds; Thymidine | 2018 |
Using Radiolabeled 3'-Deoxy-3'-
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Dexamethasone; Dideoxynucleosides; Humans; Isotope Labeling; Lung Neoplasms; Mice; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Treatment Outcome | 2018 |
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.
Topics: Animals; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dideoxynucleosides; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Lung Neoplasms; Mice; Positron-Emission Tomography | 2014 |
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Dideoxynucleosides; Female; Glioblastoma; HEK293 Cells; Humans; Mice; Microvessels; Positron-Emission Tomography; Survival Analysis; Tyrosine; Vascular Endothelial Growth Factor A | 2016 |
Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Equilibrative Nucleoside Transporter 1; Female; Gene Knockdown Techniques; Gene Knockout Techniques; Humans; Mice; Mice, Knockout; Neoplasms; Positron-Emission Tomography; RNA, Messenger; RNA, Small Interfering; Spleen; Thioinosine; Thymidine; Thymidine Kinase; Transfection | 2010 |
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
Topics: Animals; Beta Particles; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Female; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Lutetium; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Receptors, Urokinase Plasminogen Activator; Substrate Specificity | 2012 |
Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Biological Transport; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dideoxynucleosides; Equilibrative Nucleoside Transporter 1; Humans; Lung Neoplasms; Male; Mice; Positron-Emission Tomography; Protein Transport | 2012 |